Advances in Brain Tumors
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Clinical Research of Cancer".
Deadline for manuscript submissions: 30 September 2026 | Viewed by 4
Special Issue Editor
Interests: stroke; neurological surgery; brain tumors
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Brain tumors pose a unique challenge for patients and providers due to the intricate nature of the brain and the aggressive molecular biology of many brain cancers. Despite substantial research investment, the treatment of malignant brain tumors has only seen minimal progress over the past four decades. This urgent need underscores the imperative for innovative technologies in diagnosis, imaging, surgery, and adjuvant treatment.
This Special Issue aims to present cutting-edge tools and techniques that have the potential to revolutionize these areas. Advanced diagnostic techniques including the use of liquid biopsies and biomarkers will be presented. It will delve into advanced imaging techniques, such as the use of artificial intelligence for molecular subtype diagnosis, and intraoperative methods that enhance outcomes, minimize risks, and provide immediate diagnostic insights. Additionally, the Special Issue will showcase new and effective therapeutic approaches, including targeted therapy and minimally invasive, less toxic, and more effective treatments.
By providing readers with unique tools and therapies, this Special Issue seeks to empower them in the pursuit of more effective diagnosis and treatment of brain tumors.
Prof. Dr. David S. Baskin
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- diagnosis
- biomarker
- treatment
- brain tumors
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
